BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 6603264)

  • 1. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
    Helland S; Ueland PM
    Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in various tissues of mice given injections of 9-beta-D-arabinofuranosyladenine.
    Helland S; Ueland PM
    Cancer Res; 1983 Apr; 43(4):1847-50. PubMed ID: 6831422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
    Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 9-beta-D-arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine on the metabolism of S-adenosylhomocysteine, S-adenosylmethionine, and adenosine in rat liver.
    Eloranta TO; Kajander EO; Raina AM
    Med Biol; 1982 Oct; 60(5):272-7. PubMed ID: 7154718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine.
    Helland S; Ueland PM
    Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity of deoxycoformycin: effect of constant infusion on adenosine deaminase, adenosine, 2'-deoxyadenosine and monoamines in the mouse brain.
    Helland S; Broch OJ; Ueland PM
    Neuropharmacology; 1983 Jul; 22(7):915-7. PubMed ID: 6604884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of aliphatic adenine analogues on S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in intact rat hepatocytes.
    Schanche JS; Schanche T; Ueland PM; HolĂ˝ A; Votruba I
    Mol Pharmacol; 1984 Nov; 26(3):553-8. PubMed ID: 6493210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of S-adenosylhomocysteine hydrolase by 9-beta-D-arabinofuranosyladenine in intact cells.
    Helland S; Ueland PM
    Cancer Res; 1982 Mar; 42(3):1130-6. PubMed ID: 7059972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells.
    Hasobe M; Mckee JG; Borcherding DR; Keller BT; Borchardt RT
    Mol Pharmacol; 1988 Jun; 33(6):713-20. PubMed ID: 2454388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.
    Hershfield MS; Kredich NM; Ownby DR; Ownby H; Buckley R
    J Clin Invest; 1979 Apr; 63(4):807-11. PubMed ID: 312296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.
    Svardal A; Djurhuus R; Ueland PM
    Mol Pharmacol; 1986 Aug; 30(2):154-8. PubMed ID: 3736540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H; Thorbecke GJ; Hirschhorn R
    Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of S-adenosylhomocysteine in tissues following pharmacological inhibition of S-adenosylhomocysteine catabolism.
    Helland S; Ueland PM
    Adv Exp Med Biol; 1986; 195 Pt B():663-6. PubMed ID: 3490128
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of 2'-deoxycoformycin-inhibited adenosine deaminase of mouse erythrocytes and leukemia L1210 in vivo.
    Agarwal RP
    Cancer Res; 1979 Apr; 39(4):1425-7. PubMed ID: 421226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inhibition of mouse liver methyltransferase enzymes following treatment with 2'-deoxycoformycin and 2'-deoxyadenosine.
    Renshaw J; Harrap KR
    Adv Exp Med Biol; 1986; 195 Pt B():673-5. PubMed ID: 3490129
    [No Abstract]   [Full Text] [Related]  

  • 19. S-adenosylhomocysteine hydrolase activity, deoxyadenosine triphosphate accumulation, and competence of thymocyte and spleen leucocyte response to mitogens in coformycin-treated mice.
    Lukey T; Snyder FF
    Biochem Pharmacol; 1983 Apr; 32(8):1399-406. PubMed ID: 6860359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
    Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.